Work

A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed PD-L1 IHC low/unknown stage IV squamous cell lung cancers.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.e21035

Authors: Paul K. Paik, Aparajita Srikakulum, Linda Su Hyun Ahn, Andrew J. Plodkowski, Kenneth K. Ng, Daniel McFarland, John Joseph Fiore, Afsheen Iqbal, Juliana Eng, Charles M. Rudin

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891135954

Cites:

Cited by: 1

Related to: 10